Practice Management News

WASHINGTON — In a Healio video exclusive, Leen Al-Sayyed, MD, gastroenterology and transplant hepatology fellow at St. Louis University, reported women with nonalcoholic steatohepatitis-cirrhosis had an increased prevalence for polypharmacy.

Oral ENT-01 treatment was safe and associated with improvements in constipation among patients with Parkinson’s disease, a study in Annals of Internal Medicine found.

WASHINGTON — Increased culturally competent care and improved access to medical transport may improve early detection of hepatocellular carcinoma in patients who live in late-stage hotspots, according to researchers at The Liver Meeting.

So, you’ve reached consensus with your partners that it’s time to sell the practice. You’ve done your research on potential platforms/buyers, and you’ve started to engage advisers. What’s next? Time to look inward.

In this edition, achalasia is associated with higher esophageal cancer risk; FDA rejects bulevirtide for hepatitis D and liver disease; real-world data on colonoscopy prep and more.

WASHINGTON — Prednisone induced a higher 90-day survival rate and lower incidence of acute kidney injury compared with anakinra and zinc sulfate in patients with severe alcohol-associated hepatitis, according to late-breaking data.

WASHINGTON — Fewer Black and Hispanic patients received curative treatment for early-stage hepatocellular carcinoma compared with white patients, according to research presented at The Liver Meeting.

WASHINGTON — Patients with cirrhosis in low- or middle-income countries had an increased risk for inpatient and 30-day mortality, likely due to disparities in transplant access, according to research presented at The Liver Meeting.

During the ACG Annual Meeting, we were happy to honor our 2022 Healio Disruptive Innovators.

The field of psychogastroenterology has grown tremendously over the years and includes mental health providers who specialize in working with patients with GI concerns.